Use of intravenous cyclophosphamide in the prevention of corneal melt: justified or not?
作者信息
Liu D T L, Chan A Y K
出版信息
Rheumatology (Oxford). 2006 Jul;45(7):920; author reply 921-2. doi: 10.1093/rheumatology/kel059. Epub 2006 Mar 31.
PMID:16581815
Abstract
摘要
相似文献
1
Use of intravenous cyclophosphamide in the prevention of corneal melt: justified or not?静脉注射环磷酰胺用于预防角膜溶解：合理与否？
Rheumatology (Oxford). 2006 Jul;45(7):920; author reply 921-2. doi: 10.1093/rheumatology/kel059. Epub 2006 Mar 31.
2
Use of intravenous cyclophosphamide in the prevention of corneal melt: justified or not?静脉注射环磷酰胺用于预防角膜溶解：合理与否？
Rheumatology (Oxford). 2005 Feb;44(2):257-8. doi: 10.1093/rheumatology/keh442. Epub 2005 Jan 5.
3
Peripheral ulcerative keratitis in rheumatoid arthritis: successful use of intravenous cyclophosphamide and comparison of clinical and serological characteristics.类风湿关节炎相关性周边溃疡性角膜炎：静脉注射环磷酰胺的成功应用及临床与血清学特征比较
Ann Rheum Dis. 2005 Jun;64(6):961-2. doi: 10.1136/ard.2004.023283.
4
5
[Value of immunosuppressive agents in corneal diseases].[免疫抑制剂在角膜疾病中的价值]
Bull Soc Ophtalmol Fr. 1984 Oct;84(10):1171-4.
6
Peripheral ulcerative keratitis in the setting of rheumatoid arthritis: treatment with immunosuppressive therapy.类风湿关节炎背景下的周边溃疡性角膜炎：免疫抑制疗法治疗
Semin Arthritis Rheum. 1995 Aug;25(1):67-73. doi: 10.1016/s0049-0172(95)80019-0.
7
[Symposium II. 4-1. Long-term immunosuppressive therapy for rheumatoid arthritis].[专题研讨会二。4 - 1. 类风湿关节炎的长期免疫抑制治疗]
Ryumachi. 1973 Jan;13(1):48-9.
8
[Immunosuppressive therapy of rheumatoid arthritis].[类风湿关节炎的免疫抑制治疗]
Ugeskr Laeger. 1971 Apr 2;133(13):605-6.
9
[Corneal marginal ulcer. Autoimmune diseases, new therapeutic aspects].
Dakar Med. 1996;Spec No:35-7.
10
[On the critical evaluation of immunosuppressive therapy in progressive chronic polyarthritis].[关于进行性慢性多关节炎免疫抑制治疗的批判性评估]
Z Gesamte Inn Med. 1969 May 15;24(10):147-8.
Zotero 插件